Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) reflects the killing mechanism of antibodies through effector cells. The efficiency of this process depends on the Fcγ receptor (FcγR). Polymorphisms in these genes can change their activity. Here we are offering our customers ePBMC® with characterized FcγRIIIA loci, which can also be used as positive control for your assay.

About FcγRIIIa Polymorphism Characterized PBMC

Immune cells are able to recognize opsonized antigens via different Fcγ-Receptors. The receptor, which induces antibody dependent cell cytotoxicity (ADCC) is the FcγRIIIA receptor (CD16). This particular receptor recognizes clustered and bounded IgG. That recognition induces ADCC in the targeted cell. Polymorphisms in the receptor are suggested to enhance or reduce ADCC efficiency.

≥10 million cells per vial Cat# CTL-GCP1

Please request for further information

Protocols

Literature

Request for Quotation


By sending this form you agree that we will use your information to answer your request or contact you. Further information on data protection can also be found in the data protection declaration on this website.

* GDPR
Loading
Your message has been sent. Thank you!